Breaking News Instant updates and real-time market news.

LMAT

LeMaitre

$35.97

1.11 (3.18%)

16:21
10/23/19
10/23
16:21
10/23/19
16:21

LeMaitre raises FY19 EPS view to 88c-90c from 84c-88c, consensus 86c

Raises FY19 revenue view to $117.2M-$118M from $115.5M-$116.7M, consensus $116.17M.

  • 23

    Oct

LMAT LeMaitre
$35.97

1.11 (3.18%)

07/25/19
FANA
07/25/19
UPGRADE
Target $37
FANA
Outperform
LeMaitre upgraded to Outperform from Neutral at First Analysis
First Analysis analyst Joseph Munda upgraded LeMaitre to Outperform from Neutral and raised his price target for the shares to $37 from $29. The analyst sees strengthening fundamentals following the company's Q2 results. Management's renewed sense of confidence in the business, coupled with a raised outlook for 2019-2020, warrants an upgrade to Outperform, Munda tells investors in a research note.
07/25/19
BRRR
07/25/19
NO CHANGE
Target $37
BRRR
Outperform
LeMaitre price target raised to $37 from $32 at Barrington
Barrington analyst Michael Petusky raised his price target for LeMaitre Vascular to $37 from $32 following the company's "solid" Q2 results. The analyst is "encouraged" by recent sales trends and thinks the company's margins could expand "meaningfully" over the next couple of years. The recent geographic expansion and new product innovations, like the just-launched XenoSure Plus, will give LeMaitre a "reasonable opportunity" to sustain its recent pickup in organic momentum over the longer term, Petusky tells investors in a research note. He maintains an Outperform rating on the shares.
07/25/19
LSCM
07/25/19
NO CHANGE
Target $34
LSCM
Hold
LeMaitre price target raised to $34 from $27 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for LeMaitre Vascular to $34 from $27 saying the company reported solid" Q2 results. The analyst, however, is hesitant to value the company at a premium to its peer group. He views the stock as fairly valued at current levels and keeps a Hold rating on the name.
10/14/19
FANA
10/14/19
UPGRADE
Target $37
FANA
Strong Buy
LeMaitre upgraded to Strong Buy from Outperform at First Analysis
First Analysis analyst Joseph Munda upgraded LeMaitre to Strong Buy from Outperform with an unchanged price target of $37. The analyst views the company's acquisition of the CardioCel and VascuCel product lines positively. The acquired products lines are differentiated and expand LeMaitre's existing portfolio of biologic products, Munda tells investors in a research note. He cites the deal and valuation for his upgrade to Strong Buy.

TODAY'S FREE FLY STORIES

ARWR

Arrowhead

$47.43

-1.08 (-2.23%)

09:33
11/18/19
11/18
09:33
11/18/19
09:33
Hot Stocks
Arrowhead presents new clinical data on candidates ARO-APOC3 and ARO-ANG3 »

Arrowhead Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

VRAY

ViewRay

$2.78

0.04 (1.46%)

09:33
11/18/19
11/18
09:33
11/18/19
09:33
Conference/Events
ViewRay participates in a conference call with Cantor Fitzgerald »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

TMUS

T-Mobile

$78.05

1.18 (1.54%)

09:32
11/18/19
11/18
09:32
11/18/19
09:32
Hot Stocks
T-Mobile CEO Legere says 'plenty of qualified candidates for CFO' »

T-Mobile CEO John Legere…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

NEXA

Nexa Resources

$8.65

-0.58 (-6.28%)

09:32
11/18/19
11/18
09:32
11/18/19
09:32
Downgrade
Nexa Resources rating change  »

Nexa Resources downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$298.18

16.14 (5.72%)

, CI

Cigna

$196.08

6.41 (3.38%)

09:31
11/18/19
11/18
09:31
11/18/19
09:31
Recommendations
Anthem, Cigna, Centene, CVS Health, Humana, Molina Healthcare, Tivity Health, UnitedHealth, WellCare analyst commentary  »

Healthcare Services…

ANTM

Anthem

$298.18

16.14 (5.72%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

TVTY

Tivity Health

$21.31

1.26 (6.28%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 22

    Nov

  • 09

    Dec

  • 10

    Dec

  • 13

    Dec

  • 06

    Feb

BAM

Brookfield

$57.38

-0.37 (-0.64%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Downgrade
Brookfield rating change  »

Brookfield downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TRIP

TripAdvisor

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Initiation
TripAdvisor initiated  »

TripAdvisor initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 25

    Nov

  • 26

    Nov

EXPE

Expedia

$95.38

0.14 (0.15%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Initiation
Expedia initiated  »

Expedia initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

BKNG

Booking Holdings

$1,846.71

-17.12 (-0.92%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Initiation
Booking Holdings initiated  »

Booking Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINC

Lincoln Educational

$1.70

(0.00%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Conference/Events
Lincoln Educational management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

TMUS

T-Mobile

$78.05

1.18 (1.54%)

, WE

We Company

$0.00

(0.00%)

09:29
11/18/19
11/18
09:29
11/18/19
09:29
Hot Stocks
T-Mobile CEO Legere says 'never was in discussions with We Work' »

T-Mobile (TMUS) CEO John…

TMUS

T-Mobile

$78.05

1.18 (1.54%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

ACTG

Acacia Research

$2.92

-0.07 (-2.35%)

09:29
11/18/19
11/18
09:29
11/18/19
09:29
Hot Stocks
Acacia Research to receive up to $400M in new capital from Starboard partnership »

Acacia Research announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$254.54

-0.415 (-0.16%)

09:27
11/18/19
11/18
09:27
11/18/19
09:27
Conference/Events
Lennox management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SFM

Sprouts Farmers Market

$19.86

-0.04 (-0.20%)

, FIVE

Five Below

$119.60

-4.77 (-3.84%)

09:27
11/18/19
11/18
09:27
11/18/19
09:27
Hot Stocks
Sprouts Farmers Market appoints Five Below CEO Joel Anderson to board »

Sprouts Farmers Market…

SFM

Sprouts Farmers Market

$19.86

-0.04 (-0.20%)

FIVE

Five Below

$119.60

-4.77 (-3.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FC

Franklin Covey

$37.50

-0.25 (-0.66%)

09:26
11/18/19
11/18
09:26
11/18/19
09:26
Conference/Events
Franklin Covey management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

I

Intelsat

$13.40

1.27 (10.47%)

09:25
11/18/19
11/18
09:25
11/18/19
09:25
Initiation
Intelsat initiated  »

Intelsat initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CLRO

ClearOne

$1.52

-0.255 (-14.41%)

09:25
11/18/19
11/18
09:25
11/18/19
09:25
Hot Stocks
ClearOne begins shipping of CONVERGENCE AV Network Manager »

ClearOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDRA

Idera Pharmaceuticals

$2.11

-0.04 (-1.86%)

09:25
11/18/19
11/18
09:25
11/18/19
09:25
Conference/Events
Idera Pharmaceuticals participates in a conference call with JPMorgan »

SMid Biotech Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

ESVIF

Ensign Energy

$0.00

(0.00%)

09:24
11/18/19
11/18
09:24
11/18/19
09:24
Conference/Events
Ensign Energy management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

09:24
11/18/19
11/18
09:24
11/18/19
09:24
Conference/Events
CFTC Commissioner participates in a panel discussion »

The Commodity Futures…

DZSI

Dasan Zhone

$7.75

0.21 (2.79%)

09:24
11/18/19
11/18
09:24
11/18/19
09:24
Hot Stocks
Dasan Zhone announces resignation of Michael Connors from board »

DASAN Zhone Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TRNO

Terreno Realty

$56.41

0.23 (0.41%)

09:23
11/18/19
11/18
09:23
11/18/19
09:23
Hot Stocks
Terreno Realty acquires property in Seattle, WA for $2.9M »

Terreno Realty acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENS

EnerSys

$68.69

1.01 (1.49%)

09:23
11/18/19
11/18
09:23
11/18/19
09:23
Conference/Events
EnerSys management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

FTNT

Fortinet

$101.49

1.42 (1.42%)

, SIEGY

Siemens

$0.00

(0.00%)

09:23
11/18/19
11/18
09:23
11/18/19
09:23
Hot Stocks
Fortinet, Siemens announce technology alliance partnership »

Fortinet (FTNT) announced…

FTNT

Fortinet

$101.49

1.42 (1.42%)

SIEGY

Siemens

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

FTNT

Fortinet

$101.49

1.42 (1.42%)

, SFTBY

SoftBank

$0.00

(0.00%)

09:21
11/18/19
11/18
09:21
11/18/19
09:21
Hot Stocks
SoftBank chooses Fortinet Secure SD-WAN to accelerate managed SD-WAN services »

Fortinet (FTNT) announced…

FTNT

Fortinet

$101.49

1.42 (1.42%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.